|
antithrombotics in DVT prophylaxis - Clinical trials results
Systematic review and meta-analysis of clinical trials
about antithrombotics in DVT prophylaxis.
Clinical trials enrolled the following type of patients :
See also:
-
antithrombotics (all clinical conditions)
-
DVT prophylaxis (all therapeutical action or mecanism)
- Other antithrombotics:
100-U/kg heparin
,
12 months
,
12 months dual antiplatelet
,
18 months dual antiplatelet
,
24 months
,
3 months
,
3-6 months
,
4 months
,
6 months
,
6-12 months
,
Abciximab
,
Abciximab+reteplase
,
acenocoumarol
,
anti-agrégant et AVK
,
anticoagulant
,
Antixarin
,
apixaban
,
ardeparin
,
Argatroban
,
ASA high dose
,
aspirin
,
aspirin + clopidogrel
,
aspirin + dipiridamol
,
aspirin + dipyridamol
,
aspirin + sulfinpyrazone
,
aspirin+clopidogrel
,
Aspirin+Dipyridamole
,
aspirine
,
atopaxar
,
Bemiparin
,
Bivalirudin
,
bivalirudin + eptifibatide
,
bivalirudin + GP2b3a inhibitors
,
Certoparin
,
certoparine + DHE
,
cilostazol
,
cilostazol + aspirin
,
clopidogrel
,
clopidogrel + aspirin
,
clopidogrel double-dose
,
cloricromene
,
complete stripping
,
compression stocking group
,
coumadin
,
coumadin low dose
,
dabigatran
,
dabigatran 110mg
,
dabigatran 150mg
,
dabigatran 220mg
,
dabigatran 450mg
,
dalteparin
,
dazoxiben
,
defibrotide
,
deltaparin
,
desirudin
,
desmin 200
,
desmin SC
,
Diclofenac
,
dicoumarol
,
dipyridamol
,
edoxaban
,
Efegatran
,
elinogrel
,
enoxaparin
,
Enoxaparin+abciximab
,
enoxaprain
,
Eptifibatide
,
Essaven
,
Etofenak
,
Exhirud ointment
,
extended dalteparin
,
extended enoxaparin
,
extended nadroparin
,
extended prophylaxis
,
extended rivaroxaban
,
extended tinzaparin
,
Fixed-dose LMWH
,
flurbiprofen
,
fluxum
,
fondaparinux
,
fraxiparin
,
GR3219B
,
Heparansulphate
,
heparin
,
heparin spraygel
,
heparin+phenprocoumon
,
heparin+warfarin
,
Héparine calcique
,
héparine de bas poids moléculaire
,
high-dose clopidogrel
,
Hirudin
,
HNF
,
hors sujet
,
hydroxychloroquine
,
idraparinux
,
indefinite
,
indobufen
,
Indomethacin
,
Inogatran
,
ketanserine
,
kétensérine
,
Lamifiban
,
ligation
,
liposomal heparin-spraygel
,
LMWH
,
LMWH at home
,
Minoctoparine
,
misc.
,
Monitoring Adjusted Antiplatelet Treatment
,
nadroparin
,
nadroparin 14d
,
nadroparin fixed-dose
,
Nimesulide
,
once daily dalteparin
,
once daily enoxaparin
,
once daily logiparin
,
once daily nadroparin
,
Oral acetamin
,
Orbofiban
,
otamixaban
,
out of hospital Ardeparin
,
out of hospital Dalteparin
,
out of hospital Enoxaparin
,
out of hospital Nadroparin
,
out of hospital UFH
,
Oxyphenbutazone
,
Parnaparin
,
Pharmuka
,
Phenindione
,
phenprocoumon
,
picotamide
,
prasugrel
,
prolongated dual antiplatelet
,
prolonged dual antiplatelet therapy
,
Prophylactic LMWH
,
Prophylactic UFH
,
Reviparin
,
rivaroxaban
,
SCH 530348
,
Sibrafiban
,
sp
,
SR123781A
,
SSHA
,
subcutaneous heparin
,
sulfinpyrazone
,
sulfinyrazone
,
suloctidil
,
sulotroban
,
tecarfarin
,
tenoxicam
,
Therapeutic LMWH
,
thrombectomy plus ECB
,
ticagrelor + aspirin
,
ticlopidine
,
ticlopidine + aspirin
,
Tinzaparin
,
tinzaparin+warfarin
,
Tirofiban
,
Topical methylthioadenosine
,
trapidil
,
triflusal
,
triflusal+coumadin medium dose
,
triple antiplatelet
,
UFH
,
UFH + aspirin
,
UFH, warfarin
,
Vasotonin forte
,
warfarin
,
warfarin + aspirin
,
warfarin low dose
,
warfarin low dose + aspirin
,
warfarin standard dose
,
Wobenzym
,
ximelagatran
,
-
antivitamins K in DVT prophylaxis
-
heparin in DVT prophylaxis
-
antiplatelets in DVT prophylaxis
-
antithrombotics in Phlebothrombosis
-
antithrombotics in Deep Vein Thrombosis
-
antithrombotics in Deep-Vein Thrombosis
-
antithrombotics in Thrombophlebitis
-
antithrombotics in DVTaaa
-
antithrombotics in TVPaaa
-
antithrombotics in Thrombosis
Entry term : Phlebothrombosis, Deep Vein Thrombosis, Deep-Vein Thrombosis, Thrombophlebitis, DVTaaa, TVPaaa, Thrombosis, , antivitamins K , heparin, antiplatelets
citeULike
|